Showing 97 of 97on this page. Filters & sort apply to loaded results; URL updates for sharing.97 of 97 on this page
Demonstration of the iADRS as an integrated measure of global disease ...
[P4–488]: THE INTEGRATED ALZHEIMER's DISEASE RATING SCALE (IADRS ...
Table 1 from The Integrated Alzheimer's Disease Rating Scale (iADRS ...
The tomography dementia rating scale (TDR)—The rating scale of ...
The iADRS as an integrated measure of cognition and function ...
Alzheimer’s Disease Assessment Scale (ADAS)
The Integrated Alzheimer’s Disease Rating Scale (iADRS) Findings from ...
Repeated measures analysis of ADAS-Cog14, ADCS-iADL, and iADRS in the ...
Expected iADRS Baseline Scores and Rate of Change by Clinical ...
Abbreviations: ADAS-Cog = Alzheimer's Disease Assessment Scale ...
Automated Scoring of Alzheimer’s Disease Atrophy Scale with Subtype ...
Understanding the Alzheimer Disease Assessment Scale
A COMBINED MEASURE OF COGNITION AND FUNCTION FOR CLINICAL TRIALS: THE ...
Minimal clinically important difference in Alzheimer's disease: Rapid ...
Donanemab Phase 3 trial shows promise in Alzheimer's treatment
Figure 2 from Meaningful Clinical Changes in Alzheimer Disease Measured ...
(PDF) Integrated Alzheimer's Disease Rating Scale: Clinically ...
Meaningful Clinical Changes in Alzheimer Disease Measured With the ...
(PDF) Demonstration of Clinical Meaningfulness of the Integrated ...
Donanemab Treatment Effects in Early Stages of Alzheimer Disease ...
Guidelines for Managing Alzheimer's Disease: Part I. Assessment | AAFP
Integrated Alzheimer's Disease Rating Scale: Clinically meaningful ...
PPT - Alzheimer Disease Assessment Scale—Cognitive Subscale (ADAS-cog ...
(PDF) A Combined Measure of Cognition and Function for Clinical Trials ...
Disease progression model using the integrated Alzheimer's Disease ...
Figure 1 from The Alzheimer’s Disease Assessment Scale–Cognitive ...
Dementia discussions in the doctor’s office are about to change | STAT
Clinical Meaningfulness in Alzheimer’s Disease Trials: Key Insights ...
What’s the difference between scoring among ADLs and IADLs.? - WizEdu
Abbreviations: 1º = primary, 2º = secondary, AD = Alzheimer's disease ...
알츠하이머병 환자의 아밀로이드 플라크에 작용하는 Donanemab의 능력
A Dementia Evaluation Tool — Radiant Nursing
Alzheimer's Disease Drug Development: Aducanumab, Lecanemab & Donanemab ...
Donanemab immunogenicity in participants with early symptomatic ...
Demonstration of Clinical Meaningfulness of the Integrated Alzheimer’s ...
APOE ε4's impact on response to amyloid therapies in early symptomatic ...
Comparison of Alzheimer's disease assessment scale-cognitive scores and ...
Alzheimer's Disease Drug Development Aducanumab, Lecanemab & Donanemab.pdf
Conceptual model. ADRD: Alzheimer disease/Alzheimer Disease-Related ...
Alzheimer's Association clinical practice guideline for the Diagnostic ...
Frontiers | A task force for diagnosis and treatment of people with ...
ANTI-TAU TRIALS FOR ALZHEIMER’S DISEASE: A REPORT FROM THE EU/US/CTAD ...
The ABC of Alzheimer's Disease: ADL and Improving Day-to-Day ...
Alzheimer Disease & Associated Disorders
Donanemab exposure‐response in early symptomatic Alzheimer's disease ...
Variability of cognitive changes after donanemab treatment - Dampney ...
Donanemab exposure and efficacy relationship using modeling in ...
Research criteria for the diagnosis of Alzheimer's disease: revising ...
Exploring the relationship between patient-relevant outcomes and ...
70178-3/asset/9ed86d1a-5be6-4113-b77c-0a3ffbdc4bfe/main.assets/gr1_lrg.jpg)
